BioMarin Pharmaceutical Inc. (BMRN)

[chmcnfunds]

Roche talks rare diseases, won't comment on Alexion, BioMarin speculation: Reuters • 11:47 AM

Is Roche (RHHBY +0.4%) really interested in Alexion (ALXN -0.4%) or BioMarin (BMRN +0.1%)? CEO Severin Schwan isn't telling, but he did say at a Paris conference that the company will "go where the science takes it, wherever it is, independent from the size of the patient population," suggesting a move into rare and orphan diseases.

Regarding the company's attempt to expand beyond core cancer treatments, Schwan mentioned autoimmune, inflammatory diseases, and neuroscience, noting that in these "three areas naturally [Roche] is a partner of choice for many companies [and] if there was an interesting opportunity outside of those established areas, I would be very open to look at it."

More on Roche/ALXN speculation here, and on BMRN chatter here

BMRN